CClinicalTrials.gg
CompletedNCT00246077Updated Apr 11, 2007

Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport

An observational study in Anemia, Sickle Cell, sponsored by Children's Mercy Hospital Kansas City. Completed at 1 site in United States. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2007-04-11.

Sponsored by Children's Mercy Hospital Kansas City · Observational

Study type
Observational
Time perspective
Other
Enrollment
5
Ages
8 Years to 18 Years
Sex
All
01

Study summary

This study is being done to see what impact having a Lifeport device has on quality of life for children with sickle cell who are getting chronic transfusions, from the child's perspective.

Read the detailed description

There is a paucity of research that focuses specifically on quality of life (QoL) among patients with sickle cell. This study aims to explore the QoL of children who are receiving chronic transfusion therapy (CTT) using a Lifeport device, which allows them to undergo erythrocytapheresis, rather than standard transfusion therapy. Erythrocytapheresis is less time consuming and is associated with less iron overload than conventional transfusion therapy; however, little is known about the implications for the child's QoL. This study will explore QoL from the child's perspective.

02

Conditions studied

  • Anemia, Sickle Cell

Browse trials for

Keywords

  • chronic transfusion therapy
  • quality of life
03

In context

Anemia, Sickle Cell

1,103 studies on the registry are indexed under Anemia, Sickle Cell; 235 are open to participants now.

This study's enrollment of 5 is below the median of 100 across 287 observational studies indexed under Anemia, Sickle Cell.

Browse Anemia, Sickle Cell studies →

Lead sponsor

Children's Mercy Hospital Kansas City is the lead sponsor of 209 studies on the registry; 22 are open to participants now.

Of its 18 completed or terminated interventional studies of FDA-regulated products, 14 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Individuals with a diagnosis of sickle cell disease between the ages of 8 \& 18 years
  • currently receiving chronic transfusion therapy via a Lifeport device
  • Individuals have been utilizing the Lifeport for at least 6 months and no more than 18 months
  • Individuals have received transfusions previously using conventional transfusion therapy (simple or exchange transfusions)
  • Individuals have permission of parents (when applicable) and assent

Exclusion criteria

Exclusion Criteria:

  • Individuals who, in the opinion of the study staff, would suffer negative consequence, psychosocial trauma, or undue stress as a result of participation
05

Study design

Time perspective
Other
Enrollment
5 participants
06

Study locations

1 site
  • The Children's Mercy Hospital
    Kansas City, Missouri 64108, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00246077
Lead sponsor
Children's Mercy Hospital Kansas City
First posted
Oct 30, 2005
Start date
Oct 2005
Completion
Dec 2005
Last update
Apr 11, 2007

Study contacts

Susan Sarcone, RN
study director · Children's Mercy Hospital Kansas City
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion